Voxel

Voxel CROIC

The Cash Return on Invested Capital (CROIC) of Voxel (VOX.WA) as of Nov 15, 2026 is 6.87 %. In the previous year, Cash Return on Invested Capital (CROIC) was 10.61 % — a change of -35.21% (lower).

CROIC

6.87 %

YoY

-35.21%

Last updated:

Cash Return on Invested Capital (CROIC) of Voxel is 2025 6.87 % . Cash Return on Invested Capital (CROIC) of Voxel was 2024 10.61 % . It decreases by -35.21% lower compared to the previous year.

The Voxel CROIC history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CROIC
Date
CROIC
Jan 1, 2018
9.66 PLN
Jan 1, 2019
8.41 PLN
Jan 1, 2020
9.03 PLN
Jan 1, 2021
18.86 PLN
Jan 1, 2022
17.14 PLN
Jan 1, 2023
17.65 PLN
Jan 1, 2024
10.61 PLN
Jan 1, 2025
6.87 PLN
The Voxel CROIC history
YEARCROICYoY
6.87 %-35.21%
10.61 %-39.90%
17.65 %+3.00%
17.14 %-9.15%
18.86 %+108.92%
9.03 %+7.36%
8.41 %-12.90%
9.66 %-42.87%
16.90 %+93.24%
8.75 %-51.09%
17.88 %+517.42%
2.90 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Voxel Stock analysis

What does Voxel do? Voxel SA generates revenue through medical services including diagnostic imaging, teleradiology, and outsourcing, alongside IT systems for hospitals and diagnostic centers. The company serves healthcare institutions with its diagnostic imaging solutions, teleradiology services, and IT infrastructure, targeting hospitals and diagnostic centers as key clients. It operates two subsidiaries, Alteris SA (95.24%-owned) and CDO Sp. z o.o. (wholly owned), which support its service offerings. Voxel SA previously held a stake in Centrum Diagnostyki i Terapii Onkologicznej Sp. z o.o. but sold it on November 7, 2012. The company's primary revenue streams come from providing diagnostic imaging services, teleradiology, and IT systems to healthcare facilities. Its subsidiaries, Alteris SA and CDO Sp. z o.o., contribute to the delivery of these services, enhancing its market presence in medical technology. Voxel SA focuses on institutional clients such as hospitals and diagnostic centers, leveraging its IT systems to improve operational efficiency in healthcare settings. Voxel SA's business model centers on delivering specialized medical services and technology solutions to healthcare providers. It operates through its subsidiaries, Alteris SA and CDO Sp. z o.o., to expand its service capabilities. The company's revenue is derived from contracts with hospitals and diagnostic centers for diagnostic imaging, teleradiology, and IT system implementation, with no mention of additional revenue sources beyond these core services. Voxel is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Voxel stock

Cash Return on Invested Capital (CROIC) of Voxel is 6.87 % in 2025.

Cash Return on Invested Capital (CROIC) of Voxel changed from 10.61 % to 6.87 %, representing a -35.21% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Cash Return on Invested Capital (CROIC) Voxel since 2006 – with annual values, charts, and detailed analysis.

CROIC measures the cash return generated on invested capital. Unlike ROIC, it uses free cash flow instead of accounting earnings, providing a purer profitability measure.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Return on Invested Capital (CROIC)'s Voxel with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Return on Invested Capital (CROIC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Return on Invested Capital (CROIC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Voxel

All Key Metrics — Voxel